Remove Networking Remove Physicians Remove Side effects
article thumbnail

HCPs use of digital

World of DTC Marketing

HCPs increasingly turn to trusted colleagues on digital networks for reliable information. The value proposition to HCP marketers is different from the value proposition that physicians want. They need to use the power of online to connect physicians and share information. Don’t tell me it can’t be done either.

article thumbnail

Can pharma really leverage social media?

World of DTC Marketing

A Mediabistro survey showed that social networks influence more than 40% of people’s health choices. According to MedData Group, 72% of physicians surveyed were active on Facebook weekly, and 38% were active on Instagram and LinkedIn weekly. To test this, we did a small campaign for a psoriasis product.

Media 238
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EndoStim Receives FDA Breakthrough Device Designation for the EndoStim System for the Treatment of Drug Refractory GERD

Legacy MEDSearch

The EndoStim system, programmed wirelessly by a physician using an external handheld controller, automatically stimulates the LES to allow it to function normally without any sensation to the patient. About EndoStim. The EndoStim System has been successfully investigated in multiple independent studies.

article thumbnail

Don’t Miss Out | DHC September Events – New Med Launch Webinar & Summit

Pharma Marketing Network

New medications that can greatly improve a patient’s quality of life and overall health can present significant side effects that often lead patients to abandon treatment. The latest research on physician preferences. Topics covered : The new realities of a virtual launch. Social media trends. REGISTER HERE.

article thumbnail

Medical Sales Strategies: How to Drive Doctors’ Recommendations

MaBiCo

Whether you are in the pharmaceuticals, dermoceuticals, OTC, medical devices, or whatever business relates with patients and their health, you need to have a clearly defined strategy on how to approach physicians. More specifically clinical trials provide a reliable evaluation for a product’s effectiveness and its side effects on humans.

article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

During the two-year project, the companies will assess the mental health side effects of the asthma drug, montelukast. Cerner Enviza will collaborate with a range of Oracle provider networks in the discovery, development and deployment of health insights and therapies.

Safety 59
article thumbnail

New Research Reveals Perceptions of the Role of AI Among Healthcare Stakeholders

Pharma Marketing Network

This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies. ” Everyone Agrees AI Needs Guardrails Conversations about AI always turn quickly to the risks.